K8 was found to reduce geographic atrophy lesion area growth by more than 50% in its first human clinical trial of the drug.

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

The studies compared the Unity Vitreoretinal Cataract System (VCS) to the Constellation Vision System and the ...

Travoprost is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Kwangdong, a top 5 pharmaceutical and healthcare company in Korea, is actively involved in research and development ...

Belite Bio completes its phase 3 trial for tinlarebant, a potential first treatment for Stargardt disease, with results ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A panelist discusses how a 50-year-old male patient with stabilized keratoconus achieved excellent visual outcomes with an IC-8 small aperture IOL by targeting slight myopia to optimize the defocus ...

Optain Health secures $26 million in Series A funding to enhance AI-driven retinal disease detection and expand its ...